NV1020
- Generic Name
- NV1020
- Drug Type
- Biotech
Overview
NV1020, a genetically engineered herpes simplex virus, is a novel anticancer therapeutic.
Background
NV1020, a genetically engineered herpes simplex virus, is a novel anticancer therapeutic.
Indication
Intended for the treatment of various forms of cancer.
Associated Conditions
No associated conditions information available.
Clinical Trials
FDA Approved Products
No FDA products found for this drug
Singapore Approved Products
No Singapore products found for this drug
Drug Development Updates
Stay informed with timely notifications on clinical trials and research advancements.
© Copyright 2025. All Rights Reserved by MedPath